Denali Therapeutics Inc (NASDAQ:DNLI)

31.24
Delayed Data
As of Jul 01
 +1.81 / +6.15%
Today’s Change
20.24
Today|||52-Week Range
79.50
-29.96%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Denali Therapeutics Inc have a median target of 72.00, with a high estimate of 105.00 and a low estimate of 39.00. The median estimate represents a +130.47% increase from the last price of 31.24.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Denali Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.56
Sales
$41.2M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.87%
 
 
 
 
 
 
Growthannually -12.41%
 
 
 
 
 
 

Sales

Growthquarterly -2.14%
 
 
 
 
 
 
Growthannually 114.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.